Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg
Description
In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention (7 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
A/Prof Li-Chuen Wong
Eczema Practical Updates for General Practice
Dr Preeti Joshi
Cow’s Milk Allergy in Infants and Children
A/Prof Michael Woodward AM
RSV Vaccine on the NIP – What You Need to Know
Clinical A/Prof Greg Katsoulotos
Inhaler Devices Workshop
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
